Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$14.89 0.21 (1.43%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 1.54(B)
Last Volume: 772,336 Avg Vol: 1,689,102
52 Week Range: $11.5 - $17.51
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  604
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 50,000 304,000 330,151 4,223,516
Total Sell Value $803,000 $4,338,050 $4,684,028 $62,649,148
Total People Sold 2 6 7 12
Total Sell Transactions 2 8 9 53
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 312
  Page 5 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   O'keeffe Charles B Director   –       •      –    2022-12-06 4 OE $0.00 $0 D/D 1,334 566,391     -
   Ingenito Gary Chief Medical Officer   •       –      –    2022-12-06 4 S $16.85 $99,718 D/D (5,918) 30,802 -8%     
   Ingenito Gary Chief Medical Officer   •       –      –    2022-12-06 4 OE $0.00 $0 D/D 14,667 36,720     -
   Mcenany Patrick J President and CEO   •       •      –    2022-12-06 4 D $0.00 $0 D/D (12,133) 3,921,307     -
   Mcenany Patrick J President and CEO   •       •      –    2022-12-06 4 OE $0.00 $0 D/D 30,834 3,933,440     -
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-12-06 4 OE $0.00 $0 D/D 14,667 42,109     -
   Denkhaus Donald A Director   –       •      –    2022-12-06 4 OE $0.00 $0 D/D 1,334 279,000     -
   Daly Richard J Director   –       •      –    2022-12-06 4 OE $0.00 $0 D/D 1,334 94,000     -
   Tierney David S Director   –       •      –    2022-12-06 4 OE $0.00 $0 D/D 1,334 309,541     -
   Miller Steve Chief Operating Officer   •       –      –    2022-11-23 4 S $17.34 $346,740 D/D (20,000) 553,791 1%     
   Coelho Philip H Director   –       •      –    2022-11-23 4 S $17.45 $174,483 D/D (9,999) 149,553 1%     
   Coelho Philip H Director   –       •      –    2022-11-22 4 S $17.30 $346,097 D/D (20,001) 159,552 1%     
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-11-22 4 S $16.53 $1,983,240 D/D (120,000) 27,442 1%     
   Miller Steve Chief Operating Officer   •       –      –    2022-11-21 4 S $15.28 $1,222,080 D/D (80,000) 573,791 -8%     
   Coelho Philip H Director   –       •      –    2022-11-21 4 S $15.23 $1,066,170 D/D (70,000) 179,553 -8%     
   Mcenany Patrick J President and CEO   •       •      –    2022-11-21 4 S $15.33 $2,299,800 D/D (150,000) 3,902,606 -8%     
   Mcenany Patrick J President and CEO   •       •      –    2022-11-21 4 OE $2.24 $336,000 D/D 150,000 4,052,606     -
   Mcenany Patrick J President and CEO   •       •      –    2022-11-18 4 S $15.62 $5,467,700 D/D (350,000) 3,902,606 -9%     
   Mcenany Patrick J President and CEO   •       •      –    2022-11-18 4 OE $2.24 $784,000 D/D 350,000 4,252,606     -
   O'keeffe Charles B Director   –       •      –    2022-11-15 4 S $16.04 $1,411,015 D/D (87,985) 565,057 -5%     
   Grande Alicia VP, Treasurer and CFO   •       –      –    2022-11-15 4 S $15.77 $946,080 D/D (60,000) 147,442 -5%     
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2022-11-14 4 OE $0.79 $151,850 D/D 105,000 116,096     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2022-11-11 4 S $16.25 $929,871 D/D (56,786) 0 -12%     
   Sundaram Preethi Chief Strategy Officer   •       –      –    2022-11-11 4 OE $5.49 $311,755 D/D 56,786 56,786     -
   Denkhaus Donald A Director   –       •      –    2022-11-11 4 S $16.59 $331,880 D/D (20,000) 277,666 -12%     
  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us